Washington: Singulair (montelukast) Neur… | DrugsMonitor.com

Singulair (montelukast) Neuropsychiatric litigation (WA) Washington focus: docket-era primer, deadlines, case review—not legal advice.

Litigation has alleged serious injuries tied to this product or device; regulatory actions, science, and defenses vary by claim and time period. This summary is general information only., Washington